SmartDose® Self Injection Platform
Source: West Pharmaceutical Services, Inc.
Consistent. Reliable. Ready to Go. The first combination product that incorporates the SmartDose Platform was recently approved by the U.S. Food and Drug Administration (FDA). West developed SmartDose® for single-use drug delivery. This wearable device is a patient-centric drug delivery device that incorporates human factors design and usability testing. The SmartDose platform is usually worn on the abdomen and pre-programmed to deliver highly viscous biologics to the patient.
SmartDose Platform highlights:
- Ideal for high-viscosity and silicone-sensitive biologic formulations
- Includes a Daikyo Crystal Zenith primary drug container with FluroTec elastomer coating
- Dual site commercial manufacturing
- Injectable Volume Range: 3.7mL
- Wear Time: Up to 2 hours
- Minimum Delivery Time: 4.5 minutes
For more information on West Pharmaceutical Services SmartDose Self-Injection Platform please visit: http://www.westpharma.com/products/self-injection-platforms/smartdose
This website uses cookies to ensure you get the best experience on our website. Learn more